{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:47:33Z","timestamp":1788911253304,"version":"build-2803163510"},"reference-count":137,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T00:00:00Z","timestamp":1674691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Radiation Oncology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.semradonc.2022.11.006","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T10:22:55Z","timestamp":1679912575000},"page":"159-171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Stereotactic Body Radiation Therapy for Spinal Metastases: Benefits and Limitations"],"prefix":"10.1016","volume":"33","author":[{"given":"Matthias","family":"Guckenberger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Dahele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wee Loon","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Sahgal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semradonc.2022.11.006_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115783","article-title":"Epidemiology of bone metastases","volume":"158","author":"Ryan","year":"2022","journal-title":"Bone"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00007632-199001000-00001","article-title":"Spinal metastases: The obvious, the occult, and the impostors","volume":"15","author":"Wong","year":"1990","journal-title":"Spine"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0003","article-title":"The cost of treating skeletal-related events in patients with prostate cancer","volume":"14","author":"Maureen","year":"2008","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0004","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.radonc.2018.01.003","article-title":"Update of the systematic review of palliative radiation therapy fractionation for bone metastases","volume":"126","author":"Rich","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0005","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.radonc.2019.06.037","article-title":"Single vs multiple fraction palliative radiation therapy for bone metastases: Cumulative meta-analysis","volume":"141","author":"Chow","year":"2019","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0006","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s000660050061","article-title":"[Remineralization and pain relief in bone metastases after after different radiotherapy fractions (10 times 3 Gy vs. 1 time 8 Gy). A prospective study]","volume":"175","author":"Koswig","year":"1999","journal-title":"Strahlenther Onkol Organ Dtsch Rontgengesellschaft Al"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0007","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.radonc.2019.01.019","article-title":"Single versus multifraction radiotherapy for spinal cord compression: A systematic review and meta-analysis","volume":"134","author":"Donovan","year":"2019","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0008","doi-asserted-by":"crossref","first-page":"e278","DOI":"10.1016\/j.wneu.2018.04.188","article-title":"Prognostic factors of ambulatory status for patients with metastatic spinal cord compression: A systematic review and meta-analysis","volume":"116","author":"Liu","year":"2018","journal-title":"World Neurosurg"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0009","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/BSD.0000000000000528","article-title":"Metastatic spinal cord compression and steroid treatment: A systematic review","volume":"30","author":"Kumar","year":"2017","journal-title":"Clin Spine Surg"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0010","article-title":"Comparison of 5\u00a0\u00d7\u00a05 Gy and 10\u00a0\u00d7\u00a03 Gy for metastatic spinal cord compression using data from three prospective trials","volume":"16","author":"D","year":"2021","journal-title":"Radiat Oncol Lond Engl"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0011","first-page":"02229","article-title":"Long-term outcomes with nivolumab plus ipilimumab or nivolumab alone versus ipilimumab in patients with advanced melanoma","volume":"21","author":"Wolchok","year":"2021","journal-title":"J Clin Oncol JCO"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0012","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.annonc.2020.04.478","article-title":"Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study","volume":"31","author":"Mok","year":"2020","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0013","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1200\/JCO.19.00934","article-title":"Five-year overall survival for patients with advanced non\u2012small-cell lung cancer treated with pembrolizumab: Results from the phase I KEYNOTE-001 study","volume":"37","author":"Garon","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0014","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","article-title":"Oligometastases","volume":"13","author":"Hellman","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0015","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S1470-2045(19)30718-1","article-title":"Characterisation and classification of oligometastatic disease: A European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation","volume":"21","author":"Guckenberger","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0016","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00066-020-01603-1","article-title":"Definition and quality requirements for stereotactic radiotherapy: Consensus statement from the DEGRO\/DGMP working group stereotactic radiotherapy and radiosurgery","volume":"196","author":"Guckenberger","year":"2020","journal-title":"Strahlenther Onkol Organ Dtsch Rontgengesellschaft Al"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0017","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ijrobp.2011.04.039","article-title":"Imaging for stereotactic spine radiotherapy: Clinical considerations","volume":"81","author":"Dahele","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0018","doi-asserted-by":"crossref","first-page":"e597","DOI":"10.1016\/j.ijrobp.2012.03.009","article-title":"International Spine Radiosurgery Consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery","volume":"83","author":"Cox","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0019","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.ijrobp.2016.03.027","article-title":"Postoperative stereotactic body radiation therapy (SBRT) for spine metastases: A critical review to guide practice","volume":"95","author":"Redmond","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0020","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3171\/2016.8.SPINE16121","article-title":"Consensus guidelines for postoperative stereotactic body radiation therapy for spinal metastases: Results of an international survey","volume":"26","author":"Redmond","year":"2017","journal-title":"J Neurosurg Spine"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0021","first-page":"1157","article-title":"Pain outcomes in patients with bone metastases from advanced cancer: Assessment and management with bone-targeting agents","volume":"23","author":"Patrick","year":"2015","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0022","doi-asserted-by":"crossref","first-page":"E1221","DOI":"10.1097\/BRS.0b013e3181e16ae2","article-title":"A novel classification system for spinal instability in neoplastic disease: An evidence-based approach and expert consensus from the Spine Oncology Study Group","volume":"35","author":"Fisher","year":"2010","journal-title":"Spine"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0023","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3171\/2010.3.SPINE09459","article-title":"Reliability analysis of the epidural spinal cord compression scale: Clinical article","volume":"13","author":"Bilsky","year":"2010","journal-title":"J Neurosurg Spine"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0024","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13014-016-0631-9","article-title":"Variability in spine radiosurgery treatment planning - results of an international multi-institutional study","volume":"11","author":"Toussaint","year":"2016","journal-title":"Radiat Oncol Lond Engl"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0025","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13014-021-01892-5","article-title":"Evaluation of inter- and intra-fraction 6D motion for stereotactic body radiation therapy of spinal metastases: Influence of treatment time","volume":"16","author":"Hadj Henni","year":"2021","journal-title":"Radiat Oncol Lond Engl"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0026","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.radonc.2007.05.021","article-title":"Precision required for dose-escalated treatment of spinal metastases and implications for image-guided radiation therapy (IGRT)","volume":"84","author":"Guckenberger","year":"2007","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0027","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.radonc.2017.04.022","article-title":"Verifying tumor position during stereotactic body radiation therapy delivery using (limited-arc) cone beam computed tomography imaging","volume":"123","author":"Hazelaar","year":"2017","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0028","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/j.prro.2019.08.006","article-title":"Frequency of large intrafractional target motions during spine stereotactic body radiation therapy","volume":"10","author":"Wu","year":"2020","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0029","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ijrobp.2011.12.039","article-title":"Impact of immobilization on intrafraction motion for spine stereotactic body radiotherapy using cone beam computed tomography","volume":"84","author":"Li","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0030","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/acm2.12271","article-title":"Comparison of four techniques for spine stereotactic body radiotherapy: Dosimetric and efficiency analysis","volume":"19","author":"Aljabab","year":"2018","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0031","doi-asserted-by":"crossref","first-page":"e595","DOI":"10.1016\/S1470-2045(15)00166-7","article-title":"Response assessment after stereotactic body radiotherapy for spinal metastasis: A report from the SPIne response assessment in Neuro-Oncology (SPINO) group","volume":"16","author":"Thibault","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0032","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1470-2045(21)00196-0","article-title":"Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: An open-label, multicentre, randomised, controlled, phase 2\/3 trial","volume":"22","author":"Sahgal","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0033","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.radonc.2018.04.030","article-title":"Randomized phase II trial evaluating pain response in patients with spinal metastases following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy","volume":"128","author":"Sprave","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0034","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.21873\/anticanres.12814","article-title":"Quality of life following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy for vertebral metastases: Secondary analysis of an exploratory phase II randomized trial","volume":"38","author":"Sprave","year":"2018","journal-title":"Anticancer Res"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0035","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ijrobp.2020.11.060","article-title":"Pain response after stereotactic body radiation therapy versus conventional radiotherapy in patients with bone metastases \u2013 a phase II, randomized controlled trial within a prospective cohort","volume":"110","author":"Pielkenrood","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0036","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.ijrobp.2019.06.382","article-title":"Radiosurgery compared to external beam radiotherapy for localized spine metastasis: Phase III results of NRG oncology\/RTOG 0631","volume":"105","author":"Ryu","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0037","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1002\/cncr.21467","article-title":"Single-fraction radiosurgery for the treatment of spinal breast metastases","volume":"104","author":"Gerszten","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0038","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/jjco\/hyz130","article-title":"A prospective multicentre feasibility study of stereotactic body radiotherapy in Japanese patients with spinal metastases","volume":"49","author":"Ito","year":"2019","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0039","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ijrobp.2020.12.045","article-title":"Long-term results of dose-intensified fractionated stereotactic body radiation therapy (SBRT) for painful spinal metastases","volume":"110","author":"Guckenberger","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): A randomised, phase 2, open-label trial","author":"Palma","year":"2019","journal-title":"The Lancet"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0041","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S1470-2045(16)30532-0","article-title":"Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: A multicentre, randomised, controlled, phase 2 study","volume":"17","author":"Gomez","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0042","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2017.3501","article-title":"Consolidative radiotherapy for limited metastatic non\u2013small-cell lung cancer: A phase 2 randomized clinical trial","volume":"4","author":"Iyengar","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0043","article-title":"Randomized trial of first-line tyrosine kinase inhibitor with or without radiotherapy for synchronous oligometastatic EGFR -mutated non-small cell lung cancer","author":"Wang","year":"2022","journal-title":"JNCI J Natl Cancer Inst"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0044","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1200\/JCO.2017.75.4853","article-title":"Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence: A prospective, randomized, multicenter phase II trial","volume":"36","author":"Ost","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0045","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/jamaoncol.2020.0147","article-title":"Outcomes of observation vs stereotactic ablative radiation for oligometastatic prostate cancer: The ORIOLE phase 2 randomized clinical trial","volume":"6","author":"Phillips","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0046","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S1470-2045(20)30537-4","article-title":"Stereotactic ablative body radiotherapy in patients with oligometastatic cancers: a prospective, registry-based, single-arm, observational, evaluation study","volume":"22","author":"Chalkidou","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0047","article-title":"Safety and survival rates associated with ablative stereotactic radiotherapy for patients with oligometastatic cancer: A systematic review and meta-analysis","author":"Lehrer","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0048","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.ijrobp.2004.04.025","article-title":"Phase I clinical evaluation of near-simultaneous computed tomographic image-guided stereotactic body radiotherapy for spinal metastases","volume":"59","author":"Chang","year":"2004","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0049","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.1002\/cncr.27530","article-title":"Phase 1\/2 trial of single-session stereotactic body radiotherapy for previously unirradiated spinal metastases","volume":"118","author":"Garg","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0050","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1470-2045(11)70384-9","article-title":"Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: A phase 1\u20132 trial","volume":"13","author":"Wang","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0051","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.breast.2019.10.016","article-title":"Stereotactic ablative body radiotherapy (SABR) for bone only oligometastatic breast cancer: A prospective clinical trial","volume":"49","author":"David","year":"2020","journal-title":"The Breast"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0052","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.radonc.2015.09.008","article-title":"Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy","volume":"118","author":"Guckenberger","year":"2016","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0053","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s12885-018-4191-2","article-title":"The SBRT database initiative of the german society for radiation oncology (DEGRO): Patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases","volume":"18","author":"Andratschke","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0054","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ijrobp.2015.05.035","article-title":"Five-year outcomes of high-dose single-fraction spinal stereotactic radiosurgery","volume":"93","author":"Moussazadeh","year":"2015","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0055","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.radonc.2019.06.003","article-title":"Low incidence of late failure and toxicity after spine stereotactic radiosurgery: Secondary analysis of phase I\/II trials with long-term follow-up","volume":"138","author":"Ning","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0056","first-page":"1","article-title":"A systematic review of evidence on malignant spinal metastases: natural history and technologies for identifying patients at high risk of vertebral fracture and spinal cord compression","volume":"17","author":"Sutcliffe","year":"2013","journal-title":"Health Technol Assess Winch Engl"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0057","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0936-6555(02)00400-4","article-title":"A Population-based study of malignant spinal cord compression in ontario","volume":"15","author":"Loblaw","year":"2003","journal-title":"Clin Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0058","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S1470-2045(22)00092-4","article-title":"Observation versus screening spinal MRI and pre-emptive treatment for spinal cord compression in patients with castration-resistant prostate cancer and spinal metastases in the UK (PROMPTS): an open-label, randomised, controlled, phase 3 trial","volume":"23","author":"Dearnaley","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0059","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/SPC.0b013e32834de701","article-title":"Malignant epidural spinal cord compression: The role of external beam radiotherapy","volume":"6","author":"Holt","year":"2012","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0060","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1002\/cncr.24993","article-title":"Radiosurgical decompression of metastatic epidural compression","volume":"116","author":"Ryu","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0061","first-page":"51","article-title":"Stereotactic radiosurgery for high-grade metastatic epidural cord compression","volume":"3","author":"Lee","year":"2014","journal-title":"J Radiosurgery SBRT"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0062","article-title":"Phase 1 study of spinal cord constraint relaxation with single session spine stereotactic radiosurgery in the primary management of patients with inoperable, previously irradiated metastatic epidural spinal cord compression","volume":"6","author":"Ghia","year":"2021","journal-title":"North Am Spine Soc J"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0063","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.ijrobp.2018.07.2023","article-title":"Phase 1 study of spinal cord constraint relaxation with single session spine stereotactic radiosurgery in the primary management of patients with inoperable, previously unirradiated metastatic epidural spinal cord compression","volume":"102","author":"Ghia","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0064","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.ijrobp.2017.12.276","article-title":"Improving quality and consistency in NRG oncology radiation therapy oncology group 0631 for spine radiosurgery via knowledge-based planning","volume":"100","author":"Younge","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0065","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.827195","article-title":"Evaluation of a dedicated software \u2018elementstm spine srs, brainlab\u00ae\u2019 for target volume definition in the treatment of spinal bone metastases with stereotactic body radiotherapy","volume":"12","author":"Rog\u00e9","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0066","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/neuonc\/not101","article-title":"Surgical resection of epidural disease improves local control following postoperative spine stereotactic body radiotherapy","volume":"15","author":"Al-Omair","year":"2013","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0067","doi-asserted-by":"crossref","first-page":"E1111","DOI":"10.1093\/neuros\/nyz349","article-title":"Postoperative stereotactic body radiotherapy for spinal metastases and the impact of epidural disease grade","volume":"85","author":"Alghamdi","year":"2019","journal-title":"Neurosurgery"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0068","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ijrobp.2021.07.1690","article-title":"Phase 2 clinical trial of separation surgery followed by stereotactic body radiation therapy for metastatic epidural spinal cord compression","volume":"112","author":"Ito","year":"2022","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0069","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3171\/2012.11.SPINE12111","article-title":"Local disease control for spinal metastases following \u201cseparation surgery\u201d and adjuvant hypofractionated or high-dose single-fraction stereotactic radiosurgery: Outcome analysis in 186 patients: Clinical article","volume":"18","author":"Laufer","year":"2013","journal-title":"J Neurosurg Spine"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0070","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/nop\/npx017","article-title":"Hybrid surgery\u2013radiosurgery therapy for metastatic epidural spinal cord compression: A prospective evaluation using patient-reported outcomes","volume":"5","author":"Barzilai","year":"2018","journal-title":"Neuro-Oncol Pract"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0071","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/os.12594","article-title":"Efficacy analysis of separation surgery combined with SBRT for spinal metastases\u2014A long-term follow-up study based on patients with spinal metastatic tumor in a single-center","volume":"12","author":"Xiaozhou","year":"2020","journal-title":"Orthop Surg"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0072","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijrobp.2019.10.011","article-title":"A phase 2 study of post-operative stereotactic body radiation therapy (SBRT) for solid tumor spine metastases","volume":"106","author":"Redmond","year":"2020","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0073","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1016\/j.prro.2021.10.004","article-title":"Stereotactic radiosurgery for postoperative spine malignancy: A systematic review and international stereotactic radiosurgery society practice guidelines","volume":"12","author":"Faruqi","year":"2022","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0074","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ijrobp.2021.04.050","article-title":"Effects of single-dose versus hypofractionated focused radiation on vertebral body structure and biomechanical integrity: development of a rabbit radiation-induced vertebral compression fracture model","volume":"111","author":"Perdomo-Pantoja","year":"2021","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0075","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1227\/00006123-199502000-00010","article-title":"Preliminary clinical experience with linear accelerator-based spinal stereotactic radiosurgery","volume":"36","author":"Hamilton","year":"1995","journal-title":"Neurosurgery"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0076","unstructured":"NHS England Evidence review: Efficacy, Toxicity and Cost-Effectiveness of Stereotactic Ablative Radiotherapy (SABR) in Patients with Cancer Undergoing Re-irradiation. https:\/\/www.england.nhs.uk\/"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0077","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3171\/2017.2.SPINE16976","article-title":"Reirradiation spine stereotactic body radiation therapy for spinal metastases: systematic review: International Stereotactic Radiosurgery Society practice guidelines","volume":"27","author":"Myrehaug","year":"2017","journal-title":"J Neurosurg Spine"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0078","doi-asserted-by":"crossref","first-page":"e409","DOI":"10.1016\/j.prro.2017.05.007","article-title":"Reirradiation of the spine with stereotactic radiosurgery: Efficacy and toxicity","volume":"7","author":"Boyce-Fappiano","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0079","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3109\/0284186X.2012.666637","article-title":"Local tumor control after retreatment of spinal metastasis using stereotactic body radiotherapy; comparison with initial treatment group","volume":"51","author":"Chang","year":"2012","journal-title":"Acta Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0080","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ijrobp.2009.07.1727","article-title":"Stereotactic radiosurgery for treatment of spinal metastases recurring in close proximity to previously irradiated spinal cord","volume":"78","author":"Choi","year":"2010","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0081","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1002\/cncr.25918","article-title":"Prospective evaluation of spinal reirradiation by using stereotactic body radiation therapy: The University of Texas MD Anderson Cancer Center Experience","volume":"117","author":"Garg","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0082","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3171\/2016.4.SPINE151523","article-title":"Re-irradiation stereotactic body radiotherapy for spinal metastases: A multi-institutional outcome analysis","volume":"25","author":"Hashmi","year":"2016","journal-title":"J Neurosurg Spine"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0083","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/1748-717X-6-173","article-title":"Spinal radiosurgery - efficacy and safety after prior conventional radiotherapy","volume":"6","author":"Nikolajek","year":"2011","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0084","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.ijrobp.2010.08.012","article-title":"Stereotactic body radiotherapy reirradiation for recurrent epidural spinal metastases","volume":"81","author":"Mahadevan","year":"2011","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0085","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1080\/0284186X.2018.1503712","article-title":"Re-irradiation for painful bone metastases using stereotactic body radiotherapy","volume":"57","author":"Ogawa","year":"2018","journal-title":"Acta Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0086","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ijrobp.2008.09.020","article-title":"Stereotactic body radiotherapy is effective salvage therapy for patients with prior radiation of spinal metastases","volume":"74","author":"Sahgal","year":"2009","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0087","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/neuros\/nyaa109","article-title":"Mature imaging-based outcomes supporting local control for complex reirradiation salvage spine stereotactic body radiotherapy","volume":"87","author":"Detsky","year":"2020","journal-title":"Neurosurgery"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0088","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1093\/jjco\/hyaa178","article-title":"Efficacy and toxicity of re-irradiation spine stereotactic body radiotherapy with respect to irradiation dose history","volume":"51","author":"Ito","year":"2021","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0089","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/jjco\/hyac070","article-title":"Risk of radiculopathy caused by second course of spine stereotactic body radiotherapy","volume":"52","author":"Ito","year":"2022","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0090","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijrobp.2010.08.021","article-title":"Reirradiation human spinal cord tolerance for stereotactic body radiotherapy","volume":"82","author":"Sahgal","year":"2012","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0091","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.3390\/cancers13194780","article-title":"Continued versus interrupted targeted therapy during metastasis-directed stereotactic radiotherapy: A retrospective multi-center safety and efficacy analysis","volume":"13","author":"Kroeze","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0092","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/neuros\/nyy059","article-title":"Histopathological findings after reirradiation compared to first irradiation of spinal bone metastases with stereotactic body radiotherapy: A cohort study","volume":"84","author":"Foerster","year":"2019","journal-title":"Neurosurgery"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0093","article-title":"Mature local control and reirradiation rates comparing spine stereotactic body radiation therapy with conventional palliative external beam radiation therapy","author":"Zeng","year":"2022","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0094","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.1016\/S1470-2045(13)70101-3","article-title":"Vertebral compression fracture after stereotactic body radiotherapy for spinal metastases","volume":"14","author":"Sahgal","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0095","doi-asserted-by":"crossref","first-page":"S347","DOI":"10.1016\/j.jacr.2018.09.019","article-title":"ACR appropriateness criteria\u00ae management of vertebral compression fractures","volume":"15","author":"Shah","year":"2018","journal-title":"J Am Coll Radiol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0096","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2022.100446","article-title":"Epidemiology of spinal metastases, metastatic epidural spinal cord compression and pathologic vertebral compression fractures in patients with solid tumors: A systematic review","volume":"35","author":"Van den Brande","year":"2022","journal-title":"J Bone Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0097","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.clon.2011.11.004","article-title":"Update on the systematic review of palliative radiotherapy trials for bone metastases","volume":"24","author":"Chow","year":"2012","journal-title":"Clin Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0098","doi-asserted-by":"crossref","first-page":"5075","DOI":"10.1200\/JCO.2008.19.3508","article-title":"Risk of fracture after single fraction image-guided intensity-modulated radiation therapy to spinal metastases","volume":"27","author":"Rose","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0099","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1200\/JCO.2013.50.1411","article-title":"Vertebral compression fracture after spine stereotactic body radiotherapy: A multi-institutional analysis with a focus on radiation dose and the spinal instability neoplastic score","volume":"31","author":"Sahgal","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0100","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3171\/2015.10.SPINE141261","article-title":"Vertebral compression fractures after stereotactic body radiation therapy: A large, multi-institutional, multinational evaluation","volume":"24","author":"Jawad","year":"2016","journal-title":"J Neurosurg Spine"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0101","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1186\/s12885-018-4777-8","article-title":"Local response and pathologic fractures following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy for spinal metastases - a randomized controlled trial","volume":"18","author":"Sprave","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0102","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.radonc.2019.08.026","article-title":"Risk factors for vertebral compression fracture after spine stereotactic body radiation therapy: Long-term results of a prospective phase 2 study","volume":"141","author":"Mantel","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0103","doi-asserted-by":"crossref","first-page":"211","DOI":"10.21037\/atm.2019.04.68","article-title":"Adjacent level fracture incidence in single fraction high dose spinal radiosurgery","volume":"7","author":"Lockney","year":"2019","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0104","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3171\/2011.11.SPINE116","article-title":"Vertebral compression fracture risk after stereotactic body radiotherapy for spinal metastases: Clinical article","volume":"16","author":"Boehling","year":"2012","journal-title":"J Neurosurg Spine"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0105","doi-asserted-by":"crossref","first-page":"e343","DOI":"10.1016\/j.ijrobp.2012.04.034","article-title":"Vertebral compression fracture (VCF) after spine stereotactic body radiation therapy (SBRT): Analysis of predictive factors","volume":"84","author":"Cunha","year":"2012","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0106","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/neuros\/nyx493","article-title":"Vertebral compression fracture after spine stereotactic body radiation therapy: A review of the pathophysiology and risk factors","volume":"83","author":"Faruqi","year":"2018","journal-title":"Neurosurgery"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0107","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ijrobp.2016.09.007","article-title":"Analysis of the factors contributing to vertebral compression fractures after spine stereotactic radiosurgery","volume":"97","author":"Boyce-Fappiano","year":"2017","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0108","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.3171\/2009.9.FOCUS09184","article-title":"Complete percutaneous treatment of vertebral body tumors causing spinal canal compromise using a transpedicular cavitation, cement augmentation, and radiosurgical technique","volume":"27","author":"Gerszten","year":"2009","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0109","doi-asserted-by":"crossref","first-page":"S238","DOI":"10.1097\/BRS.0000000000001823","article-title":"Stereotactic body radiotherapy for spinal metastases: What are the risks and how do we minimize them?","volume":"41","author":"Chang","year":"2016","journal-title":"Spine"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0110","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3171\/2017.5.SPINE1746","article-title":"Safety and utility of kyphoplasty prior to spine stereotactic radiosurgery for metastatic tumors: A clinical and dosimetric analysis","volume":"28","author":"Barzilai","year":"2018","journal-title":"J Neurosurg Spine"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0111","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0360-3016(78)90144-X","article-title":"Radiation myelopathy of the cervical spinal cord: Time, dose and volume factors","volume":"4","author":"Abbatucci","year":"1978","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0112","first-page":"1","article-title":"Stereotactic body radiosurgery for spinal metastatic disease: an evidence-based review","volume":"2011","author":"Hall","year":"2011","journal-title":"Int J Surg Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0113","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.ijrobp.2007.11.075","article-title":"The radiation dose\u2013response of the human spinal cord","volume":"71","author":"Schultheiss","year":"2008","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0114","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.ijrobp.2009.04.095","article-title":"Radiation dose\u2013volume effects in the spinal cord","volume":"76","author":"Kirkpatrick","year":"2010","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0115","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.semradonc.2008.04.005","article-title":"The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery","volume":"18","author":"Kirkpatrick","year":"2008","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0116","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.semradonc.2008.04.004","article-title":"The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction","volume":"18","author":"Brenner","year":"2008","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0117","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.radonc.2013.09.005","article-title":"Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small cell lung cancer","volume":"109","author":"Guckenberger","year":"2013","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0118","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ijrobp.2012.05.007","article-title":"Probabilities of radiation myelopathy specific to stereotactic body radiation therapy to guide safe practice","volume":"85","author":"Sahgal","year":"2013","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0119","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ijrobp.2008.09.028","article-title":"Bath and shower effect in spinal cord: the effect of time interval","volume":"73","author":"Philippens","year":"2009","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0120","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ijrobp.2009.05.023","article-title":"Spinal cord tolerance for stereotactic body radiotherapy","volume":"77","author":"Sahgal","year":"2010","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0121","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11060-022-04037-0","article-title":"Radiation myelopathy following stereotactic body radiation therapy for spine metastases","volume":"159","author":"Ong","year":"2022","journal-title":"J Neurooncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0122","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijrobp.2019.09.038","article-title":"Spinal cord dose tolerance to stereotactic body radiation therapy","volume":"110","author":"Sahgal","year":"2021","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0123","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0360-3016(79)90663-1","article-title":"Sequential radiotherapy and adriamycin in the management of bronchogenic carcinoma: The question of additive toxicity","volume":"5","author":"Ruckdeschel","year":"1979","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0124","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0090-8258(91)90041-3","article-title":"Radiation myelitis: A complication of concurrent cisplatin and 5-fluorouracil chemotherapy with extended field radiotherapy for carcinoma of the uterine cervix","volume":"43","author":"Bloss","year":"1991","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0125","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0360-3016(98)00107-2","article-title":"Radiation myelopathy following transplantation and radiotherapy for non\u2013Hodgkin's lymphoma","volume":"41","author":"Chao","year":"1998","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0126","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.clon.2005.03.004","article-title":"Fatal radiation myelopathy after high-dose busulfan and melphalan chemotherapy and radiotherapy for Ewing's Sarcoma: A review of the literature and implications for practice","volume":"17","author":"Seddon","year":"2005","journal-title":"Clin Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0127","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.ijrobp.2019.11.417","article-title":"Existence of a dose-length effect in spinal nerves receiving single-session stereotactic ablative radiation therapy","volume":"106","author":"Hrycushko","year":"2020","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0128","doi-asserted-by":"crossref","first-page":"E12","DOI":"10.3171\/2016.11.FOCUS16348","article-title":"Peripheral nervous system injury after high-dose single-fraction image-guided stereotactic radiosurgery for spine tumors","volume":"42","author":"Stubblefield","year":"2017","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0129","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/neuros\/nyaa583","article-title":"Prognostic factors associated with surviving less than 3 months vs greater than 3 years specific to spine stereotactic body radiotherapy and late adverse events","volume":"88","author":"Zeng","year":"2021","journal-title":"Neurosurgery"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0130","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.radonc.2009.04.018","article-title":"Brachial plexopathy from stereotactic body radiotherapy in early-stage NSCLC: Dose-limiting toxicity in apical tumor sites","volume":"93","author":"Forquer","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0131","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1080\/0284186X.2019.1601255","article-title":"Radiation-induced brachial plexus toxicity after SBRT of apically located lung lesions","volume":"58","author":"Lindberg","year":"2019","journal-title":"Acta Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0132","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1118\/1.3438081","article-title":"Stereotactic body radiation therapy: The report of AAPM Task Group 101: Stereotactic body radiation therapy: The report of TG101","volume":"37","author":"Benedict","year":"2010","journal-title":"Med Phys"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0133","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13014-021-01822-5","article-title":"Estimating the tolerance of brachial plexus to hypofractionated stereotactic body radiotherapy: A modelling-based approach from clinical experience","volume":"16","author":"Kapitanova","year":"2021","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0134","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3171\/2017.8.SPINE17162","article-title":"Myositis following spine radiosurgery for metastatic disease: A case series","volume":"28","author":"Lockney","year":"2018","journal-title":"J. Neurosurg. Spine"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0135","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.ijrobp.2018.02.035","article-title":"Long-term outcomes after stereotactic radiosurgery for spine metastases: Radiation dose\u2013response for late toxicity","volume":"101","author":"Ling","year":"2018","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0136","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.clon.2020.02.030","article-title":"Vertebral fractures following stereotactic body radiotherapy for spine oligometastases: A multi-institutional analysis of patient outcomes","volume":"32","author":"Abbouchie","year":"2020","journal-title":"Clin Oncol"},{"key":"10.1016\/j.semradonc.2022.11.006_bib0137","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.prro.2021.07.004","article-title":"A volumetric dosimetry analysis of vertebral body fracture risk after single fraction spine stereotactic body radiation therapy","volume":"11","author":"Lee","year":"2021","journal-title":"Pract Radiat Oncol"}],"container-title":["Seminars in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053429622000789?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053429622000789?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:52:32Z","timestamp":1760950352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053429622000789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":137,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S1053429622000789"],"URL":"https:\/\/doi.org\/10.1016\/j.semradonc.2022.11.006","relation":{},"ISSN":["1053-4296"],"issn-type":[{"value":"1053-4296","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stereotactic Body Radiation Therapy for Spinal Metastases: Benefits and Limitations","name":"articletitle","label":"Article Title"},{"value":"Seminars in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semradonc.2022.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}